JOIN THE CLINICAL TRIAL
A PHASE III OF ONARTUZUMAB (METMAB) WITH TARCEVA AGAINST TARCEVA ALONE FOR ADVANCED OR METASTATIC LUNG CANCER!
THIS IS A FIRST LINE TREATMENT
NCT01456325, OAM4971g
A blog about research, awareness, prevention, treatment and survivorship of Breast Cancer and all cancers, including targeted scientific research and a grassroots approach to increase screening for cancer, especially in the low income and under-insured population of El Paso, Texas, with a view to expand this new health care model to many other 'minority' populations across the United States and beyond
No comments:
Post a Comment